Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-Β1-induced inflammatory signaling

Laboratory Investigation

Volumn 90, Issue 10, 2010, Pages 1507-1516

  Ki, Mi Ran ^a   Goo, Moon Jung ^a   Park, Jin Kyu ^a   Hong, Il Hwa ^a   Ji, Ae Ri ^a   Han, Seon Young ^a   You, Sang Young ^a   Lee, Eun Mi ^a   Kim, Ah Young ^a   Park, Sang Joon ^a   Lee, Hyun Joo ^b   Kim, Shin Yoon ^b   Jeong, Kyu Shik ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Helicobacter pylori; hepatic fibrosis; hepatic stellate cells; inflammation; TGF 1

Indexed keywords

ALPHA FETOPROTEIN; CARBON TETRACHLORIDE; CYCLINE; CYTOKINE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROGENESIS; HELICOBACTER PYLORI; IN VITRO STUDY; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; STELLATE CELL;

ALPHA-FETOPROTEINS; ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; I-KAPPA B PROTEINS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77957261598     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.109     Document Type: Article

References (55)

1. Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 1999;94(11 Suppl):S11-S16.
2. Cave DR. Transmission and epidemiology of Helicobacter pylori. Am J Med 1996;100(5A):12S-18S.
3. Yamada T, Searle JG, Ahnen D, et al. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994;272:65-69.
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345: 784-789.
5. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005;128:1567-1578. (Pubitemid 40692553)
6. Wotherspoon AC. Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori. Annu Rev Med 1998;49:289-299. (Pubitemid 28197455)
7. Stasi R, Sarpatwari A, Segal JB, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009;113:1231-1240.
8. Pietroiusti A, Diomedi M, Silvestrini M, et al. Cytotoxin-associated gene- A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106:580-584.
9. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286: 327-334. (Pubitemid 32656163)
10. Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005;45:1219-1222. (Pubitemid 40523140)
11. Ki MR, Shin DG, Park JS, et al. Frequency of vacuolating cytotoxin A (VacA)-positive Helicobacter pylori seropositivity and TGF-beta(1) decrease in atrial fibrillation. Int J Cardiol 2009. doi:10.1016/ j.ijcard.2009.12.009 [e-pub ahead of print].
12. Imai J, Yamada T, Saito T, et al. Eradication of insulin resistance. Lancet 2009;374:264.
13. Ponzetto A, Pellicano R, Leone N, et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypoth 2000;54:275-277. (Pubitemid 30170974)
14. Rocha M, Avenaud P, Ménard A, et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005;54:396-401. (Pubitemid 40299097)
15. Ponzetto A, Pellicano R, Leone N, et al. Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med 2000;56:206-210. (Pubitemid 30255942)
16. Leone N, Pellicano R, Brunello F, et al. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev 2003;27:494-497. (Pubitemid 37506964)
17. Nilsson HO, Taneera J, Castedal M, et al. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000;38:1072-1076. (Pubitemid 30140562)
18. Huang Y, Fan XG, Wang ZM, et al. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004;57:1273-1277. (Pubitemid 39611512)
19. Ward JM, Fox JG, Anver MR, et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994;86:1222-1227.
20. Pellicano R, Ménard A, Rizzetto M, et al. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008;8: 254-260. (Pubitemid 351382026)
21. Goo MJ, Ki MR, Lee HR, et al. Helicobacter pylori Promotes Hepatic Fibrosis in the Animal Model. Lab Invest 2009;89:1291-1303.
22. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007;13:1324-1332. (Pubitemid 350073596)
23. Vogel S, Piantedosi R, Frank J, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000;41:882-893. (Pubitemid 30434319)
24. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-1331.
25. Marra F, Efsen E, Romanelli RG, et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2002;119:466-478. (Pubitemid 30621997)
26. Naumann M, Rudel T, Wieland B, et al. Coordinate activation of activator protein 1 and inflammatory cytokines in response to Neisseria gonorrhoeae epithelial cell contact involves stress response kinases. J Exp Med 1998;188:1277-1286. (Pubitemid 28478016)
27. Zhang M, Fraser D, Phillips A. ERK, p38, and Smad signaling pathway differentially regulate transforming growth factor-1 autoinduction in proximal tubular epithelial cells. Am J Pathol 2006;169: 1282-1293. (Pubitemid 351194363)
28. Takeda K, Akira S. TLR signaling pathways. Semi Immunol 2004;16:3-9. (Pubitemid 38147427)
29. Ki MR, Lee HR, Goo MJ, et al. Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008;294:G635-G647.
30. Cowley S, Paterson H, Kemp P, et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994;77:841-852. (Pubitemid 24187682)
31. Rancourt RC, Hayes DD, Chess PR, et al. Growth arrest in G1 protects against oxygen-induced DNA damage and cell death. J Cell Physiol 2002;193:26-36. (Pubitemid 34969125)
32. Reeves HL, Dack CL, Peak M, et al. Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. J Hepatol 2000;32:465-472. (Pubitemid 30136862)
33. Huber MA, Denk A, Peter RU, et al. The IKK-2/IkBa/NFkB pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in IkBa-deficient mice. J Biol Chem 2002;277:1268-1275. (Pubitemid 34968879)
34. Tanos T, Marinissen MJ, Leskow FC, et al. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 2005;280:18842-18852. (Pubitemid 41379586)
35. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 2005;19:136-138. (Pubitemid 40069943)
36. Abdel-Hady H, Zaki A, Badra G, et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007;37:1026-1033. (Pubitemid 350028329)
37. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002;283:G256-G265. (Pubitemid 34791290)
38. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218. (Pubitemid 40385459)
39. Yoshida K, Matsuzaki K, Mori S, et al. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinasedependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pahtol 2005;164:1029-1039. (Pubitemid 40524428)
40. Carlson ME, Conboy MJ, Hsu M, et al. Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell 2009;8:676-689.
41. Nakagawa H, Maeda S, Hikiba Y, et al. Deletion of apoptosis signalregulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology 2008;135:1311-1321.
42. Ip YT, Davis RJ. Signal transduction by c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 1998;10:205-219. (Pubitemid 28174763)
43. Guo YL, Baysal K, Kang B, et al. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 1998;273: 4027-4034. (Pubitemid 28103267)
44. Schwabe RF, Bradham CA, Uehara T, et al. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 2003;37:824-832. (Pubitemid 36397393)
45. Kluwe J, Pradere JP, Gwak GY, et al. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology 2010;138:347-359.
46. Sommerfeld A, Reinehr R, Häussinger D. Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. J Biol Chem 2009;284:22173-22183.
47. Wheeler MD, Kono H, Yin M, et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001;31:1544-1549. (Pubitemid 34026339)
48. García-Trevijano ER, Iraburu MJ, Fontana L, et al. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology 1999;29:960-970. (Pubitemid 29109616)
49. Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol Gastrointest Liver Physiol 1996;270:G660-G666. (Pubitemid 126756561)
50. Yu L, Hébert MC, Zhang YE. TGF-b receptor-activated p38 MAP kinase mediates Smad-independent TGF-b responses. EMBO J 2002;21:3749-3759. (Pubitemid 34787048)
51. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-b signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009;21:166-176.
52. Cho CH, Parashurama N, Park EYH, et al. Homogeneous differentiation of hepatocytes-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J 2008;22:898-909. (Pubitemid 351348141)
53. Kordes C, Sawitza I, Müller-Marbach A, et al. CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun 2007;352:410-417. (Pubitemid 44838502)
54. Martin de las Mulas J, Gomez-Villamandos JC, Perez J, et al. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin. Res Vet Sci 1995;59:124-127.
55. Berasain C, Perugorria MJ, Latasa MU, et al. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med 2009;234:713-725.